Acellular Tissue Engineered Vessel (ATEV)

· Humacyte, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Acellular Tissue Engineered Vessel (ATEV), covering 2025-08-24 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular Disease and Dialysis Access

See pricing